Key market opportunities for Rebyota include rising CDI recurrence rates and hospital infections, expanding regulatory support for microbiome drugs, increased adoption in gastroenterology, and growing acceptance of microbiota-based therapies. Tariffs encourag…
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Rebyota Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
The… [+7255 chars]









